Drugs / PF-06842874
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04124653 | Oct 2019 → Jul 2021 | — | Pfizer | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PF-06842874 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04124653 ↗ |
| Modality | Small molecule | — CHEMBL5095191 ↗ |
| Route | Oral | “SINGLE ASCENDING ORAL DOSES OF PF-06842874 ADMINISTERED” NCT04124653 ↗ |